Riise T - Search Results

1

Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.

Lossius A, Riise T, Pugliatti M, Bjørnevik K, Casetta I, Drulovic J, Granieri E, Kampman MT, Landtblom AM, Lauer K, Magalhaes S, Myhr KM, Pekmezovic T, Wesnes K, Wolfson C, Holmøy T. Lossius A, et al. Among authors: riise t. Mult Scler. 2014 May;20(6):669-74. doi: 10.1177/1352458513505693. Epub 2013 Sep 26. Mult Scler. 2014. PMID: 24072723 Clinical Trial.

2

Early prognostic factors for disability in multiple sclerosis, a European multicenter study.

Riise T, Grønning M, Fernández O, Lauer K, Midgard R, Minderhoud JM, Nyland H, Pálffy G, Poser S, Aarli JA. Riise T, et al. Acta Neurol Scand. 1992 Mar;85(3):212-8. doi: 10.1111/j.1600-0404.1992.tb04031.x. Acta Neurol Scand. 1992. PMID: 1575007 Clinical Trial.

3

Epidemiologic trends in multiple sclerosis in Møre and Romsdal, Norway: a prevalence/incidence study in a stable population.

Midgard R, Riise T, Nyland H. Midgard R, et al. Among authors: riise t. Neurology. 1991 Jun;41(6):887-92. doi: 10.1212/wnl.41.6.887. Neurology. 1991. PMID: 2046935

4

Infections in childhood and adolescence in multiple sclerosis. A case-control study.

Grønning M, Riise T, Kvåle G, Albrektsen G, Midgard R, Nyland H. Grønning M, et al. Among authors: riise t. Neuroepidemiology. 1993;12(2):61-9. doi: 10.1159/000110302. Neuroepidemiology. 1993. PMID: 8232705

5

Multiple sclerosis and cancer in Norway. A retrospective cohort study.

Midgard R, Glattre E, Grønning M, Riise T, Edland A, Nyland H. Midgard R, et al. Among authors: riise t. Acta Neurol Scand. 1996 Jun;93(6):411-5. doi: 10.1111/j.1600-0404.1996.tb00019.x. Acta Neurol Scand. 1996. PMID: 8836302

6

Environmental risk factors in MS: a case-control study in Moscow.

Gusev E, Boiko A, Lauer K, Riise T, Deomina T. Gusev E, et al. Among authors: riise t. Acta Neurol Scand. 1996 Dec;94(6):386-94. doi: 10.1111/j.1600-0404.1996.tb00050.x. Acta Neurol Scand. 1996. PMID: 9017026

7

Treatment of relapsing-remittent multiple sclerosis with recombinant human interferon-alfa-2a: design of a randomised, placebo-controlled, double blind trial in Norway.

Nyland H, Myhr KM, Lillås F, Smievoll AI, Riise T, Nortvedt M, Nilsen R. Nyland H, et al. Among authors: riise t. Mult Scler. 1996 Jul;1(6):372-5. doi: 10.1177/135245859600100618. Mult Scler. 1996. PMID: 9345420 Clinical Trial.

8

Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway.

Myhr KM, Riise T, Barrett-Connor E, Myrmel H, Vedeler C, Grønning M, Kalvenes MB, Nyland H. Myhr KM, et al. Among authors: riise t. J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):539-42. doi: 10.1136/jnnp.64.4.539. J Neurol Neurosurg Psychiatry. 1998. PMID: 9576551 Free PMC article.

9

Interferon-alpha2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Norwegian Study Group on Interferon-alpha in Multiple Sclerosis.

Myhr KM, Riise T, Green Lilleås FE, Beiske TG, Celius EG, Edland A, Jensen D, Larsen JP, Nilsen R, Nortvedt MW, Smievoll AI, Vedeler C, Nyland HI. Myhr KM, et al. Among authors: riise t. Neurology. 1999 Mar 23;52(5):1049-56. doi: 10.1212/wnl.52.5.1049. Neurology. 1999. PMID: 10102427 Clinical Trial.

10

Quality of life in multiple sclerosis: measuring the disease effects more broadly.

Nortvedt MW, Riise T, Myhr KM, Nyland HI. Nortvedt MW, et al. Among authors: riise t. Neurology. 1999 Sep 22;53(5):1098-103. doi: 10.1212/wnl.53.5.1098. Neurology. 1999. PMID: 10496273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page